NSE/CRAMC

CRAMCCRAMC

NSE Equity · NSE

₹278.14+3.55%

52-wk low52-WEEK RANGE52-wk high

₹217.25+28.0% from low ·-20.7% from high₹350.6

Price chart · 1M–10Y · daily-close

NSE bhavcopy + 10Y historical

CRAMC-7.43% · 1Y

Range high ₹353.4Range low ₹214.2Latest ₹278.14123 bars · daily-close · NSE bhavcopy + 10Y history

NSE EquityAsset ManagementSmallcap

Stock scorecard

Auto-computed from latest ratios + sector context · not a buy/sell signal

Composite33/100

Performance

Low

Hasn't fared well — amongst the weak performers.

· 52w return -7.4% — underperformer
· Just above 200-DMA (+0.9%)

Valuation

High

Looks expensive vs the sector.

· P/E 27.2 close to sector median 24.8
· P/B 8.20 above sector median

Growth

—

Not enough historical data.

Profitability

High

Showing good signs of profitability & efficiency.

· ROE 30.1% — high-quality compounder
· Top quartile ROE in Other

DVM composite · Durability · Valuation · Momentum

Trendlyne-style 3-axis composite · all drivers shown below · not a buy/sell signal

CompositeB(64/100)

Durability

A+

100/100

Financially resilient — strong quality + solvency profile.

Show 2 drivers

Debt/Equity0.03 (100pt)
ROE30.1% (100pt)

Valuation

35/100

Trading at a premium — growth must keep delivering to justify.

Show 4 drivers

P/E vs sector (27.2 / 24.8)110% (54pt)
P/B8.20 (0pt)
Dividend yield1.08% (27pt)
EV/EBITDA19.8 (40pt)

Momentum

57/100

Constructive setup — momentum building, not extended.

Show 3 drivers

52w change-7.4% (36pt)
RSI (14)67.5 (88pt)
MACD regimebullish (75pt)

Valuation positioning

Current ratio vs sector peer distribution

P/E (TTM)27.25

FAIR

CheapestP/E 27.2 near sector median.Most expensive

P/B8.20

OVERVALUED

CheapestP/B 8.20 at 81th %ile of sector.Most expensive

EV/EBITDA19.78

OVERVALUED

SWOT analysis

Auto-derived from ratios + sector context + forensics · research only, not a recommendation

STRENGTHS · 3

High-quality compounder (ROE 30.1%)
Above 20% ROE consistently flags capital-efficient businesses
Lean balance sheet (D/E 0.03)
Low leverage means earnings are less sensitive to rate cycles
Top quartile ROE in Other
Rank 46 of 1000 peers

WEAKNESSES · 0

No material weaknesses flag from the numbers

OPPORTUNITIES · 0

No strong near-term catalysts visible

THREATS · 0

No immediate threats from the data

RETURNS · DAILY-CLOSE BASED

3Y+ shown as CAGR

+3.6%

+5.8%

+16.7%

-8.8%

-7.4%

—

10Y

—

Peer	Last close	1Y change	Mcap ₹Cr	P/E	P/B	ROE	D/E	Rev YoY
CRAMCTHIS Canara Robeco Asset Management Company Limited	₹278.14	—	5,564	27.2	8.20	30.1%	0.03	—
ABCAPITAL Aditya Birla Capital Limited	₹340.4	+68.1%	89,888	25.8	2.79	10.8%	4.60	+17.6%
ABBOTINDIA Abbott India Limited	₹25,785	-16.6%	54,547	35.8	13.60	38.0%	0.04	+9.6%
360ONE 360 ONE WAM LIMITED	₹1,113.3	+16.7%	44,744	38.7	4.77	12.3%	1.47	+35.0%
3MINDIA 3M India Limited	₹31,410	+4.4%	35,158	92.9	21.83	23.5%	0.06	+6.1%
AADHARHFC Aadhar Housing Finance Limited	₹496.45	+3.5%	21,173	20.8	3.05	14.6%	2.55	—
ABDL Allied Blenders and Distillers Limited	₹573.8	+76.4%	16,176	60.4	10.70	17.7%	0.67	+5.8%
AAVAS Aavas Financiers Limited	₹1,347.9	-37.8%	10,612	17.1	2.26	13.3%	3.08	+13.3%
63MOONS 63 moons technologies limited	₹662.7	-9.8%	8,006	—	0.92	-0.2%	0.00	-6.3%

ASK AXEL

Dig deeper into CRAMC

Axel can fetch latest news, peer valuation, consensus estimates, insider activity, and concall commentary for CRAMC — all in one sourced reply.

Ask free in chat

Run these tools on CRAMC

Historical return →

"If I had bought CRAMC in year X"

Rolling returns →

Worst/best 1/3/5/7/10-yr windows

Buy-the-dip backtester →

Dip-buying vs SIP on CRAMC

Brokerage + charges →

All-in cost for trading CRAMC

Research tool · not investment advice.

Axel Markets is an information + analytics product. We are not a SEBI-registered Research Analyst (RA) or Investment Adviser (IA). Nothing on this page is a buy, sell, or hold recommendation. Past performance is not indicative of future returns. Verify all data against the authoritative source (NSE, BSE, AMFI, SEBI, company RHP / factsheet) before acting. Daily OHLCV sourced primarily from our NSE bhavcopy ingest (public sec_bhavdata_full CSV), with Stooq as a fallback for historical gaps. Split + bonus adjusted. Excludes dividends. Not a recommendation. Past performance does not predict future returns. For authoritative live quotes see NSE / BSE directly.

CRAMCCRAMC

Price chart · 1M–10Y · daily-close

Stock scorecard

DVM composite · Durability · Valuation · Momentum

Valuation positioning

SWOT analysis

Fundamentals

Pros and cons

Sector-relative context

Analyst consensus

Company + balance sheet snapshot

Peer comparison · Other

Ask Axel about CRAMC

Recent news

Dig deeper into CRAMC

Run these tools on CRAMC

Technical snapshot

Dividends + splits history

Stock scorecard

Fundamentals

Pros and cons

Sector-relative context

Analyst consensus

Company + balance sheet snapshot

Recent news

DVM composite · Durability · Valuation · Momentum

Valuation positioning

SWOT analysis

Peer comparison · Other